Gundelfingen, Germany

Ute Weiershausen


Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 1988-1992

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Ute Weiershausen: Innovator in Pharmaceutical Chemistry

Introduction

Ute Weiershausen is a prominent inventor based in Gundelfingen, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for combating neoplastic diseases. With a total of 6 patents to her name, her work has had a notable impact on medical research and treatment options.

Latest Patents

Among her latest patents, Ute has developed N-(2'-aminophenyl)-benzamide derivatives, which are useful for combating neoplastic diseases. This invention not only provides a process for the preparation of these benzamide derivatives but also includes pharmaceutical compositions containing them and methods for their use. Additionally, she has worked on N-phenylbenzamide derivatives, which are designed to control refractory tumors in mammals. These innovations highlight her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout her career, Ute Weiershausen has been associated with notable companies such as Godecke Aktiengesellschaft and Goedecke Aktiengesellschaft. Her work in these organizations has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Ute has worked alongside esteemed colleagues, including Gerhard Satzinger and Edgar Fritschi. These collaborations have further enriched her research and development efforts, leading to innovative solutions in pharmaceutical chemistry.

Conclusion

Ute Weiershausen's contributions to the field of pharmaceutical chemistry are significant and impactful. Her innovative patents and collaborations demonstrate her dedication to advancing medical research and improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…